Glico conducted in vivo human clinical trials with Cluster Dextrin® (Highly Branched Cyclic Dextrin/HBCD). The attendant theses were reviewed, and consequently accepted for publication in the journal Bioscience, Biotechnology and Biochemistry, and are now available to readers.
The studies showed that during a cycling exercise, 24 practiced adult males experienced significantly less exhaustion after being administered 15 grams of Cluster Dextrin than a similar group given the same amount of maltodextrin. When interviewed they described more energetic performance at both 30 and 60 minute intervals after taking Cluster Dextrin. Additionally, blood was drawn after 30 minutes and examined for blood sugar levels, which tended to be higher in the Cluster Dextrin group. This suggests that it offers a pronounced benefit in promoting endurance and reducing fatigue during exercise.
Cluster Dextrin was developed by Ezaki Glico Co. Ltd. and is distributed by GlicoNutrition Co. Ltd. It offers the optimal benefit a carbohydrate-based supplement can provide in the performance of vigorous exercise.
As an energy source in sports drinks, Cluster Dextrin has low osmotic pressure, and empties swiftly from stomach to small intestine. There it quickly breaks down to enter the bloodstream, thereby sustaining a high blood sugar level. This metabolic regime shows Cluster Dextrin to be the most suitable supplement yet developed for drinks used in the performance of high-endurance sports.
Representatives of Glico will be on hand at Supply Side West this October (Booth 18101) to answer questions about this study.